Online Only Articles

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center and the Jon J van Rood Center for Clinical Transfusion Research, Sanquin-Leiden University Medical Center, The Netherlands
HOVON Data Center, Erasmus MC Cancer Institute – Clinical Trial Center, Rotterdam
Dept. of Hematology, Erasmus MC, Rotterdam
Dept. of Hematology, Academic Medical Center Amsterdam, The Netherlands
Dept. of Internal Medicine, Albert Schweitzer Hospital, Dordrecht
Department of Internal Medicine, Diakonessenhuis, Utrecht
Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center and the Jon J van Rood Center for Clinical Transfusion Research, Sanquin-Leiden University Medical Center, The Netherlands
Dept. of Hematology, VU University Medical Center, Amsterdam
Dept. of Internal Medicine, Jeroen Bosch Hospital, Den Bosch
Dept. of Hematology, Radboud University Medical Centre, Nijmegen
Dept of Internal Medicine, Máxima Medical Center, Veldhoven
Dept. of Internal Medicine, Medisch Spectrum Twente, Enschede
Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein
Dept. of Laboratory Medicine, Radboud University Medical Center, Nijmegen
Dept. of Internal Medicine, Westfriesgasthuis, Hoorn
Dept. of Internal Medicine, Meander Hospital, Amersfoort
Dept. of Internal Medicine, HagaZiekenhuis, Den Haag
Dept. of Internal Medicine, Tergooiziekenhuizen, Blaricum
Dept. of Hematology, VU University Medical Center, Amsterdam
HOVON Data Center, Erasmus MC Cancer Institute – Clinical Trial Center, Rotterdam
HOVON Data Center, Erasmus MC Cancer Institute – Clinical Trial Center, Rotterdam
Waterland hospital, Purmerend
Dept. of Internal Medicine, Spaarne hospital, Hoofddorp
Dept. of Internal Medicine, Lievensberg Hospital, Bergen op Zoom, The Netherlands
Dept. of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands
Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein
Vol. 100 No. 3 (2015): March, 2015 https://doi.org/10.3324/haematol.2014.110213